1. Home
  2. KE vs DNA Comparison

KE vs DNA Comparison

Compare KE & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

N/A

Current Price

$23.22

Market Cap

634.9M

Sector

Technology

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$7.35

Market Cap

520.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KE
DNA
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
634.9M
520.6M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
KE
DNA
Price
$23.22
$7.35
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$28.00
$8.50
AVG Volume (30 Days)
191.6K
1.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
66.18
46.49
EPS
1.13
N/A
Revenue
$1,431,378,000.00
$170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$20.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.60
$5.37
52 Week High
$33.19
$17.58

Technical Indicators

Market Signals
Indicator
KE
DNA
Relative Strength Index (RSI) 38.60 45.20
Support Level N/A $6.21
Resistance Level $27.12 $7.38
Average True Range (ATR) 1.31 0.55
MACD -0.29 -0.04
Stochastic Oscillator 23.60 25.94

Price Performance

Historical Comparison
KE
DNA

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: